Farapulse boosts Boston Scientific’s Q4 electrophysiology sales by 172%
Boston Scientific is reaping the rewards from the energised PFA market opportunity in atrial fibrillation treatment.

Boston Scientific is reaping the rewards from the energised PFA market opportunity in atrial fibrillation treatment.
The oversubscribed Series C round was led by US digital health investors Transformation Capital.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Medical Technology is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
JP Morgan 2025: Intuitive Surgical continues to battle GLP-1RA pressures
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
Innovation driving expansion in cardiovascular devices market
Smartwatch app could help people quit smoking